144 related articles for article (PubMed ID: 37594060)
1. [Risk factors for cancer-related cognitive impairment in breast and colorectal cancer patients who undergo chemotherapy].
Iranzo P; Callejo A; Arbej J; Menao S; Isla D; Andrés R
An Sist Sanit Navar; 2023 Aug; 46(2):. PubMed ID: 37594060
[TBL] [Abstract][Full Text] [Related]
2. Impact of TNF-α (rs1800629) and IL-6 (rs1800795) Polymorphisms on Cognitive Impairment in Asian Breast Cancer Patients.
Chae JW; Ng T; Yeo HL; Shwe M; Gan YX; Ho HK; Chan A
PLoS One; 2016; 11(10):e0164204. PubMed ID: 27701469
[TBL] [Abstract][Full Text] [Related]
3. Immediate-term cognitive impairment following intravenous (IV) chemotherapy: a prospective pre-post design study.
Khan OF; Cusano E; Raissouni S; Pabia M; Haeseker J; Bosma N; Ko JJ; Li H; Kumar A; Vickers MM; Tang PA
BMC Cancer; 2019 Feb; 19(1):150. PubMed ID: 30764801
[TBL] [Abstract][Full Text] [Related]
4. Association between cognitive impairment and guideline adherence for application of chemotherapy in older patients with breast cancer: Results from the prospective multicenter BRENDA II study.
Leinert E; Schwentner L; Blettner M; Wöckel A; Felberbaum R; Flock F; Kühn T; Denkinger MD; Janni W; Kreienberg R; Singer S;
Breast J; 2019 May; 25(3):386-392. PubMed ID: 30945393
[TBL] [Abstract][Full Text] [Related]
5. Chemotherapy was not associated with cognitive decline in older adults with breast and colorectal cancer: findings from a prospective cohort study.
Shaffer VA; Merkle EC; Fagerlin A; Griggs JJ; Langa KM; Iwashyna TJ
Med Care; 2012 Oct; 50(10):849-55. PubMed ID: 22683591
[TBL] [Abstract][Full Text] [Related]
6. Cognitive complaints after breast cancer treatments: examining the relationship with neuropsychological test performance.
Ganz PA; Kwan L; Castellon SA; Oppenheim A; Bower JE; Silverman DH; Cole SW; Irwin MR; Ancoli-Israel S; Belin TR
J Natl Cancer Inst; 2013 Jun; 105(11):791-801. PubMed ID: 23606729
[TBL] [Abstract][Full Text] [Related]
7. The cognitive sequelae of standard-dose adjuvant chemotherapy in women with breast carcinoma: results of a prospective, randomized, longitudinal trial.
Wefel JS; Lenzi R; Theriault RL; Davis RN; Meyers CA
Cancer; 2004 Jun; 100(11):2292-9. PubMed ID: 15160331
[TBL] [Abstract][Full Text] [Related]
8. Adjuvant chemotherapy in early breast cancer.
Ejlertsen B
Dan Med J; 2016 May; 63(5):. PubMed ID: 27127018
[TBL] [Abstract][Full Text] [Related]
9. Neuropsychological Effects of Chemotherapy: Systematic Review of Longitudinal Studies on Objective Cognitive Impairment in Breast Cancer Patients.
Kim HJ; Kim JEE; Jung SO; Lee D; Abraham I
Cancer Nurs; 2023 May-Jun 01; 46(3):E159-E168. PubMed ID: 35324504
[TBL] [Abstract][Full Text] [Related]
10. Chemotherapy-associated cognitive impairments in Korean cancer patients: Risk factors and functional outcome.
Kim HJ; Barsevick AM; Chan A; Chae JW
Psychooncology; 2018 Aug; 27(8):1995-2001. PubMed ID: 29744963
[TBL] [Abstract][Full Text] [Related]
11. Effects of Adjuvant Chemotherapy on Cognitive Function of Patients With Early-stage Colorectal Cancer.
Sales MVC; Suemoto CK; Apolinario D; Serrao V; Andrade CS; Conceição DM; Amaro E; de Melo BAR; Riechelmann RP
Clin Colorectal Cancer; 2019 Mar; 18(1):19-27. PubMed ID: 30297263
[TBL] [Abstract][Full Text] [Related]
12. Cognitive effects of adjuvant endocrine therapy in older women treated for early-stage breast cancer: a 1-year longitudinal study.
Underwood EA; Jerzak KJ; Lebovic G; Rochon PA; Elser C; Pritchard KI; Tierney MC
Support Care Cancer; 2019 Aug; 27(8):3035-3043. PubMed ID: 30610433
[TBL] [Abstract][Full Text] [Related]
13. Longitudinal investigation of cognitive deficits in breast cancer patients and their gray matter correlates: impact of education level.
Perrier J; Viard A; Levy C; Morel N; Allouache D; Noal S; Joly F; Eustache F; Giffard B
Brain Imaging Behav; 2020 Feb; 14(1):226-241. PubMed ID: 30406352
[TBL] [Abstract][Full Text] [Related]
14. Association of proinflammatory cytokines and chemotherapy-associated cognitive impairment in breast cancer patients: a multi-centered, prospective, cohort study.
Cheung YT; Ng T; Shwe M; Ho HK; Foo KM; Cham MT; Lee JA; Fan G; Tan YP; Yong WS; Madhukumar P; Loo SK; Ang SF; Wong M; Chay WY; Ooi WS; Dent RA; Yap YS; Ng R; Chan A
Ann Oncol; 2015 Jul; 26(7):1446-51. PubMed ID: 25922060
[TBL] [Abstract][Full Text] [Related]
15. [Prevalence and characteristics of chemotherapy-related cognitive impairment in patients with breast cancer].
Park JH; Bae SH; Jung YS; Jung YM
J Korean Acad Nurs; 2015 Feb; 45(1):118-28. PubMed ID: 25743740
[TBL] [Abstract][Full Text] [Related]
16. Efficacy of Acupuncture Therapy for Chemotherapy-Related Cognitive Impairment in Breast Cancer Patients.
Tong T; Pei C; Chen J; Lv Q; Zhang F; Cheng Z
Med Sci Monit; 2018 May; 24():2919-2927. PubMed ID: 29735975
[TBL] [Abstract][Full Text] [Related]
17. Verbal memory in breast cancer patients treated with chemotherapy with doxorubicin and cyclophosphamide.
Andryszak P; Wiłkość M; Żurawski B; Izdebski P
Eur J Cancer Care (Engl); 2018 Jan; 27(1):. PubMed ID: 28850754
[TBL] [Abstract][Full Text] [Related]
18. Breast cancer plus adjuvant chemotherapy- related cognitive impairment: a case study.
Fischer B
Neurocase; 2019; 25(3-4):138-144. PubMed ID: 31237172
[TBL] [Abstract][Full Text] [Related]
19. Cognitive Changes After Adjuvant Treatment in Older Adults with Early-Stage Breast Cancer.
Lange M; Heutte N; Noal S; Rigal O; Kurtz JE; Lévy C; Allouache D; Rieux C; Lefel J; Clarisse B; Leconte A; Veyret C; Barthélémy P; Longato N; Tron L; Castel H; Eustache F; Giffard B; Joly F
Oncologist; 2019 Jan; 24(1):62-68. PubMed ID: 29934409
[TBL] [Abstract][Full Text] [Related]
20. Prechemotherapy Levels of Plasma Dehydroepiandrosterone and Its Sulfated Form as Predictors of Cancer-Related Cognitive Impairment in Patients with Breast Cancer Receiving Chemotherapy.
Toh YL; Shariq Mujtaba J; Bansal S; Yeo A; Shwe M; Lau AJ; Chan A
Pharmacotherapy; 2019 May; 39(5):553-563. PubMed ID: 30892712
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
